Human placental vascular development: Vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4213-4224

  Geva, Eli ^a,b,c,d   Ginzinger, David G ^a,b,c,d   Zaloudek, Charles J ^a,b,c,d   Moore, Dan H ^a,b,c,d   Byrne, Annette ^a,b,c,d   Jaffe, Robert B ^a,b,c,d  

^a Center for Reproductive Sciences   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; COMPLEMENTARY DNA; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST; TRANSCRIPTION REGULATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; BASE SEQUENCE; BLOOD PRESSURE; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; PROTEINS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0036739927     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020195     Document Type: Article

References (43)

1. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J 2000 Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248
2. Carmeliet P 2000 Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395
3. Ferrara N, Davis-Smyth T 1997 The biology of vascular endothelial growth factor. Endocr Rev 18:4-25
4. Ferrara N 2000 Vascular endothelial growth factor and the regulation of angiogenesis. Rec Prog Horm Res 55:15-35
5. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Davis S, Yancopoulos GD 1996 Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 27:1161-1169
6. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD 1996 Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
7. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W 1998 Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 23:529-532
8. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM 1998 Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514-18521
9. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD 1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
10. Charnock-Jones DS, Burton GJ 2000 Placental vascular morphogenesis. Baillieres Best Pract Res Clin Obstet Gynaecol 14:953-968
11. Ong S, Lash G, Baker PN 2000 Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 14:969-980
12. Ahmed A, and Perkins J 2000 Angiogenesis and intrauterine growth restriction. Baillieres Best Pract Res Clin Obstet Gynaecol 14:981-998
13. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy 2000 Am J Obstet Gynecol 183:S1-S22
14. Cunningham FG, Gant NF, Leveno KJ, Gilstrap III LC, Hauth JC, Wenstrom KD 2001 Hypertensive disorders in preganacy. Williams obstetrics. 21st ed. New York: McGraw-Hill; 570
15. Cunningham FG, Gant NF, Leveno KJ, Gilstrap III LC, Hauth JC, Wenstrom KD 2001 Fetal growth disorders. Williams obstetrics. 21st ed. New York: McGraw-Hill; 746
16. Brenner WE, Edelman DA, Hendricks CH 1976 A standard of fetal growth for the United States of America. Am J Obstet Gynecol 126:555-564
17. Chomczynski P, Sacchi N 1997 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
18. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, Gray JW, Jensen RH 2000 Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 60:5405-5409
19. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB 1994 In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab 79:316-322
20. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB 1996 Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 81:353-359
21. Shifren JL, Mesiano S, Taylor RN, Ferrara N, Jaffe RB 1998 Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. J Clin Endocrinol Metab 83:1342-1347
22. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD 2000 Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6:460-463
23. Dean AG, Dean JA, Goulombier D 1997 Epi Info, version 6.04b: a word processing, database and statistics program for epidemiology and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention
24. Vellman PF 1997 Data Desk Statistics Guide version 6.0. Ithaca, NY: Data Description Inc.; 20/A-20/10
25. Benirschke K, Kaufmann P 1995 Pathology of the human placenta. 3rd ed. New York: Springer-Verlag; 1-871
26. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N 1999 VEGF is required for growth and survival in neonatal mice. Development 126:1149-1159
27. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y 1995 Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74
28. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M, Morla AO 2001 Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 276:26516-26525
29. Bowen JA, Hunt JS 1999 Expression of cell adhesion molecules in murine placentas and a placental cell line. Biol Reprod 60:428-234
30. Thirkill TL, Douglas GC 1999 The vitronectin receptor plays a role in the adhesion of human cytotrophoblast cells to endothelial cells. Endothelium 6:277-290
31. Douglas GC, Thirkill TL, Blankenship TN 1999 Vitronectin receptors are expressed by macaque trophoblast cells and play a role in migration and adhesion to endothelium. Biochim Biophys Acta 1452:36-45
32. Dunk C, Shams M, Nijjar S, Rhaman M, Qio Y, Bussolati B, Ahmed A 2000 Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 156:2185-2199
33. Goldman-Wohl DS, Ariel I, Greenfield C, Lavy Y, Yagel S 2000 Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling. Mol Hum Reprod 6:81-87
34. Suzuki T, Higgins PJ, Crawford DR 2000 Control selection for RNA quantitation. BioTechniques 29:332-337
35. Ahmed AS, Li XF, Dunk CE, Whittle MJ, Rollason T 1995 Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12:235-243
36. Vuorela P, Carpen O, Tulppala M, Halmesmaki E 2000 VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod 6:276-282
37. Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS 1996 Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. Hum Reprod 11:1090-1098
38. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E 2001 Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 7:205-210
39. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH 1997 Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99:2139-2151
40. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ 1997 Regulation of human placental development by oxygen tension. Science 277:1669-1672
41. Kaufmann P, Luckhardt M, Leiser R 1998 Three-dimensional representation of the fetal vessel system in the human placenta. Trophoblast Res 3:113-137
42. Mandriota SJ, Pepper MS 1998 Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83:852-859
43. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M. Honda Y 1999 Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274:15732-15739